Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

82.48

+2.24 (2.79%)

At close: Jan 29, 2026, 4:00 PM EST

81.01

-1.47 (-1.78%)

After-hours: Jan 29, 2026, 5:18 PM EST

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2019 - 2020
Period Ending	Jan '26 Jan 29, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2019 - 2020
Market Capitalization	804	429	5	6	20	85	Upgrade
Market Cap Growth	727.78%	8742.00%	-18.98%	-70.74%	-75.79%	-	Upgrade
Enterprise Value	743	393	0	0	14	67	Upgrade
Last Close Price	82.48	60.66	1.17	1.60	6.15	35.71	Upgrade
PB Ratio	13.65	7.29	1.19	1.23	2.67	5.51	Upgrade
P/TBV Ratio	13.65	7.29	1.19	1.23	2.67	5.52	Upgrade
Debt / Equity Ratio	0.00	0.00	0.02	0.01	0.01	-	Upgrade
Quick Ratio	35.68	35.68	10.92	24.16	8.00	31.12	Upgrade
Current Ratio	36.10	36.10	11.32	24.26	8.11	31.38	Upgrade
Return on Equity (ROE)	-27.93%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%	Upgrade
Return on Assets (ROA)	-18.80%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%	Upgrade
Return on Capital Employed (ROCE)	-16.60%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%	Upgrade
Earnings Yield	-1.09%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%	Upgrade
Buyback Yield / Dilution	-59.58%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q